Literature DB >> 23904296

Clinicopathologic analysis of coxsackievirus a6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions.

Wen-Hung Chung1, Shin-Ru Shih, Ching-Fen Chang, Tzou-Yien Lin, Yhu-Chering Huang, Shih-Chen Chang, Ming-Tsan Liu, Yu-Shien Ko, Ming-Chung Deng, Yea-Ling Liau, Lung-Huang Lin, Tou-Hwei Chen, Chih-Hsun Yang, Hsin-Chun Ho, Jheng-Wei Lin, Chun-Wei Lu, Chin-Fang Lu, Shuen-Iu Hung.   

Abstract

BACKGROUND: The cutaneous manifestations of human enterovirus (HEV) infection are usually limited, such as hand-foot-mouth disease. By comparison, Stevens-Johnson syndrome (SJS) is a life-threatening severe cutaneous adverse reaction (SCAR), mainly caused by drugs. During the HEV outbreaks in 2010-2012 in Taiwan, we identified 21 patients who developed widespread blistering mucocutaneous reactions without any suspected drug causality.
METHODS: We screened possible pathogen(s) for detecting human herpes virus (HHV1-HHV7), HEV, or Mycoplasma pneumoniae infections using throat swab virus cultures, real-time PCR, DNA sequencing, immunochemistry and electron microscopy analyses.
RESULTS: Coxsackievirus A6 (CVA6) DNA was identified in the blistering skin lesions in 6 of 21 patients. Cytotoxic T lymphocytes and natural killer cells expressing granulysin predominantly infiltrated into the skin lesions, sharing the histopathological features with SJS. Intact CVA6 viral particles were identified in the blister fluids and skin lesions by electron microscopy. The phylogenetic analysis of the viral genome showed the CVA6 DNA sequence sharing higher similarity (97.6%-98.1%) to CVA6 strains reported from Finland at 2008.
CONCLUSIONS: This study identifies a new variant of CVA6 as the causative agent for severe mucocutaneous blistering reactions mimicking SCAR. An awareness of this unusual presentation of HEV infection is needed in the epidemic area.

Entities:  

Keywords:  coxsackievirus A6; granulysin; hand-foot-mouth disease; severe cutaneous adverse reactions

Mesh:

Substances:

Year:  2013        PMID: 23904296     DOI: 10.1093/infdis/jit383

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.

Authors:  Zhenjie Zhang; Zhaopeng Dong; Juan Li; Michael J Carr; Dongming Zhuang; Jianxing Wang; Yawei Zhang; Shujun Ding; Yigang Tong; Dong Li; Weifeng Shi
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

Review 2.  Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.

Authors:  S Aswathyraj; G Arunkumar; E K Alidjinou; D Hober
Journal:  Med Microbiol Immunol       Date:  2016-07-12       Impact factor: 3.402

Review 3.  Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances.

Authors:  Teresa Bellón
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.228

4.  Unusual skin manifestation of hand, foot and mouth disease associated with coxsackievirus A6: cases report.

Authors:  Susheera Chatproedprai; Therdpong Tempark; Nasamon Wanlapakorn; Jiratchaya Puenpa; Siriwan Wananukul; Yong Poovorawan
Journal:  Springerplus       Date:  2015-07-17

5.  The Epidemiological Study of Coxsackievirus A6 revealing Hand, Foot and Mouth Disease Epidemic patterns in Guangdong, China.

Authors:  Hanri Zeng; Jing Lu; Huanying Zheng; Lina Yi; Xue Guo; Leng Liu; Shannon Rutherford; Limei Sun; Xiaohua Tan; Hui Li; Changwen Ke; Jinyan Lin
Journal:  Sci Rep       Date:  2015-05-21       Impact factor: 4.379

6.  Genome Sequence of Coxsackievirus A6, Isolated during a Hand-Foot-and-Mouth Disease Outbreak in Finland in 2008.

Authors:  Riikka Osterback; Satu Koskinen; Pirjo Merilahti; Juha-Pekka Pursiheimo; Soile Blomqvist; Merja Roivainen; Asta Laiho; Petri Susi; Matti Waris
Journal:  Genome Announc       Date:  2014-10-16

7.  Molecular evolution and the global reemergence of enterovirus D68 by genome-wide analysis.

Authors:  Yu-Nong Gong; Shu-Li Yang; Shin-Ru Shih; Yhu-Chering Huang; Pi-Yueh Chang; Chung-Guei Huang; Kuo-Chin Kao; Han-Chung Hu; Yi-Chun Liu; Kuo-Chien Tsao
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

8.  Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: a potential role of recombination in emergence and pathogenicity.

Authors:  Eleanor Gaunt; Heli Harvala; Riikka Österback; Vattipally B Sreenu; Emma Thomson; Matti Waris; Peter Simmonds
Journal:  J Gen Virol       Date:  2015-01-22       Impact factor: 3.891

Review 9.  Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Authors:  Rebecca Pavlos; Katie D White; Celestine Wanjalla; Simon A Mallal; Elizabeth J Phillips
Journal:  Immunol Allergy Clin North Am       Date:  2017-11       Impact factor: 3.479

10.  Characterization of VP1 sequence of Coxsackievirus A16 isolates by Bayesian evolutionary method.

Authors:  Guolian Zhao; Xun Zhang; Changmin Wang; Guoqing Wang; Fan Li
Journal:  Virol J       Date:  2016-07-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.